What is CG Oncology's price / sales?

CG Oncology (CGON) reported price / sales of 1,126.9× in Q1 2026.

How has CG Oncology's price / sales changed year-over-year?

CG Oncology's price / sales decreased by 60.0% year-over-year, from 2,819.6× to 1,126.9×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

CG Oncology CGON Price / sales

Price / sales at other companies

PfizerPFE

2.5×+0.2×

Johnson & JohnsonJNJ

6.1×+1.6×

Gilead SciencesGILD

5.8×+1.0×

ImmunityBio, Inc.IBRX

56.2×-26.1×

Tango TherapeuticsTNGX

52.4×+48.8×

Summit TherapeuticsSMMT

8,008.9×+7,666×

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

market cap/total revenue=1,126.9×

Based on the most recent quarter.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's price / sales?: CG Oncology (CGON) reported price / sales of 1,126.9× in Q1 2026.
How has CG Oncology's price / sales changed year-over-year?: CG Oncology's price / sales decreased by 60.0% year-over-year, from 2,819.6× to 1,126.9×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.